Sembolic 15MG/3ML Reusable Pen Injection

AboutSembolic 15MG/3ML Reusable Pen contains Semaglutide, a once-weekly injectable GLP-1 receptor agonist used to improve blood sugar control in type 2 diabetes and support weight management.Usage Instructions: Inject once weekly subcutaneously (abdomen, thigh, or upper arm) at any time, with or without meals. Use with compatible reusable pen device. Rotate injection sites each week. Start with 0.25mg weekly, titrate as prescribed.Benefits: Improves glycemic control in type 2 diabetes, promotes clinically significant weight loss, reduces cardiovascular risk, lowers HbA1c, suppresses appetite, and improves metabolic health.How it Works: Semaglutide is a GLP-1 analogue that activates GLP-1 receptors, enhancing glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and reducing appetite via hypothalamic pathways.Side Effects: Common: nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, injection site reactions, fatigue. Serious: acute pancreatitis, gallbladder disease, acute kidney injury, hypersensitivity reactions, diabetic retinopathy complications, thyroid C-cell tumors.Safety Advice: Contraindicated in type 1 diabetes, DKA, personal/family history of medullary thyroid carcinoma or MEN2. Monitor renal function, blood glucose, and for signs of pancreatitis. Report severe abdominal pain, vision changes, or allergic reactions. Use effective contraception.Storage: Refrigerate at 2-8°C before first use. After first use, may store below 25°C or refrigerate for up to 6 weeks. Do not freeze. Protect from light. Keep pen cap on. Needle must be removed after each injection.